Dr Agnes Vitry

Adjunct Senior Research Fellow UniSA Clinical & Health Sciences

City East Campus (P4-22)
tel +61 8 830 22392

email Agnes.Vitry@unisa.edu.au

Available for media comment
Research Degree Supervisor

About me

I am a Senior Lecturer at the School of Pharmacy and Health Sciences. My research focuses on three main areas: - medicines policies in Australia and the Western Pacific Region: regulatory approval, funding, pricing, managed entry agreements, affordability, usage, and pharmaceutical promotion; - quality use of medicines in people with comorbidities (elderly people, people living with cancer, residents of nursing homes). - systematic reviews of trial and observational evidence on health outcomes of medicines. In the recent years, I have collaborated with numerous organisations including the Australian Government’s Department of Health (Pharmaceutical Benefits Scheme (PBS) Post-Market Reviews), the Australian Commission on Safety and...

UniSA Clinical & Health Sciences

UniSA Clinical & Health Sciences is addressing society’s most critical and emerging health needs through quality teaching, learning and research excellence.

Tweets by @UniversitySA

Research

Research focus

Public Health and Health Services
Clinical Sciences
Medical and Health Sciences
Pharmacology and Pharmaceutical Sciences
Policy and Administration

Highlights

Quality use of medicines,Pharmaco-epidemiology,Medicines policies, pharmaceutical regulations, transparency of medicine agencies,Quality of medicines information for health professionals and consumers, clinical guidelines,Drug promotion, quality use of medicines, conflicts of interests,Assessment of new medicines

Research

Outputs

Research outputs for the last seven years are shown below. To see earlier years visit ORCID, ResearcherID or Scopus

Open access indicates that an output is open access.

Chapters

Year	Output
2018	Vitry, AI & Shute, R 2018, 'Access to high-cost medicines in Australia', in ZUD Babar (eds), Equitable access to high-cost pharmaceuticals, Academic Press, UK, ch. 11 , pp. 165-181. 1
2017	Nguyen, TA, Vitry, A & Roughead, EE 2017, 'Pharmaceutical policy in Vietnam', in Z Babar (ed.), Pharmaceutical policy in countries with developing healthcare systems, 1st ed., ADIS - Springer International Publishing, Switzerland, ch. 5, pp. 75-94. 8
2015	Vitry, AI, Thai, L & Roughead, EE 2015, 'Pharmaceutical pricing policies in Australia', in ZUD Babar (ed.), Pharmaceutical prices in the 21st century, Springer, Germany, ch. 1, pp. 1-23. 5 3
2011	Vitry, A & Löfgren, H 2011, 'Health consumer groups and the pharmaceutical industry: is transparency the answer?', in H Lofgren, EE de Leeuw & M Leahy (eds), Democratising health: consumer groups in the policy process, Edward Elgar Publishing Ltd, Cheltenham, UK, ch. 16, pp. 239 - 254. 4

Journal Articles

Year	Output
2022	Coro, DG, Hutchinson, AD, Dyer, KA, Banks, S, Koczwara, B, Corsini, N, Vitry, A & Coates, AM 2022, ''Food for thought'-the relationship between diet and cognition in breast and colorectal cancer survivors: a feasibility study', Nutrients, vol. 14, no. 1, article no. 71. Open access 6
2022	Gheybi, K, Buckley, E, Vitry, A & Roder, D 2022, 'Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis', Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention, vol. 80, article no. 102246, pp. 1-8.
2021	Mintzes, B & Vitry, A 2021, ''Drugs to avoid': can we improve prescribing appropriateness?', Drug and Therapeutics Bulletin, vol. 59, no. 11, pp. 1. 1
2021	Post, D, Vitry, A & Baldock, KL 2021, 'Evaluating changes in student health, wellbeing and social circumstances before and during COVID-19 pandemic restrictions in Australia', PEERJ, vol. 9, article no. e12078, pp. 1-10. Open access 5
2021	Vitry, A & Mintzes, B 2021, ''Drugs to avoid' to improve quality use of medicines: how is Australia faring?', Journal of Pharmaceutical Policy and Practice, vol. 14, no. 1, article no. 60, pp. 1-9. Open access 1 27
2021	Vitry, A, Forte, G & White, J 2021, 'Access to controlled medicines in low-income countries: listening to stakeholders in the field', International Journal of Health Services, vol. 51, no. 3, pp. 404-411. Open access
2020	Caughey, GE, Inacio, MC, Bell, J S, Vitry, A I & Shakib, S 2020, 'Inclusion of older people reflective of real-world clinical practice in cardiovascular drug trials', Journal of the American Heart Association, vol. 9, no. 21, pp. 1-8. Open access 5 4 2
2020	Ng, HS, Koczwara, B, Roder, D, Chan, RJ & Vitry, A 2020, 'Patterns of health service utilisation among the Australian population with cancer compared with the general population', Australian Health Review, vol. 44, no. 3, pp. 470-479. 3
2019	Fabbri, A, Swandari, S, Lau, E, Vitry, A & Mintzes, B 2019, 'Pharmaceutical industry funding of health consumer groups in Australia: a cross-sectional analysis', International Journal of Health Services, vol. 49, no. 2, pp. 273-293. Open access 16 16 49
2019	Hillen, JB, Vitry, A & Caughey, GE 2019, 'Medication-related quality of care in residential aged care: an Australian experience', International Journal for Quality in Health Care, vol. 31, no. 4, pp. 298-306. Open access 6 6 14
2019	Ng, HS, Vitry, A, Koczwara, B, Roder, D & McBride, ML 2019, 'Patterns of comorbidities in women with breast cancer: a Canadian population-based study', Cancer Causes and Control, vol. 30, no. 9, pp. 931-941. Open access 14 13
2018	Grover, P, Babar, ZUD, Oehmen, R & Vitry, A 2018, 'Medicines access programs to cancer medicines in Australia and New Zealand: an exploratory study', Health Policy, vol. 122, no. 3, pp. 243-249. Open access 3 5 4
2018	Ng, HS, Koczwara, B, Roder, D & Vitry, A 2018, 'Changes in the prevalence of comorbidity in the Australian population with cancer, 2007-2014', Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention, vol. 54, pp. 56-62. Open access 7 7
2018	Ng, HS, Koczwara, B, Roder, D & Vitry, A 2018, 'Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study', Prostate Cancer and Prostatic Diseases, vol. 21, pp. 403-410. Open access 21 21 30
2018	Ng, HS, Koczwara, B, Roder, D, Niyonsenga, T & Vitry, A 2018, 'Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study', Journal of Comorbidity, vol. 8, no. 1, pp. 16-24. Open access 1
2018	Ng, HS, Koczwara, B, Roder, DM, Niyonsenga, T & Vitry, A I 2018, 'Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis', Medical Journal of Australia, vol. 208, no. 1, pp. 24-28. Open access 12 10 3
2018	Ng, HS, Roder, D, Koczwara, B & Vitry, A 2018, 'Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study', Asia Pacific Journal of Clinical Oncology, vol. 14, pp. 181-192. 36 36
2018	Thai, LP, Vitry, AI & Moss, JR 2018, 'Price and utilisation differences for statins between four countries', Expert Review of Pharmacoeconomics and Outcomes Research: Informing Decision-Making in the Delivery of Cost-Effective Healthcare, vol. 18, no. 1, pp. 71-81. 1 2
2017	Caughey, GE, Tait, K, Vitry, A I & Shakib, S 2017, 'Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity', Patient Preference and Adherence, vol. 11, pp. 131-140. Open access 15 12
2017	Hillen, J, Vitry, A & Caughey, G 2017, 'Evaluating medication-related quality of care in Australian aged care: a role for collaborative health services', Journal of Pharmacy Practice and Research, vol. 47, no. 1, pp. 63-66. 3
2017	Hillen, J, Vitry, A & Caughey, GE 2017, 'Disease burden, comorbidity and geriatric syndromes in the Australian aged care population', Australasian Journal on Ageing, vol. 36, no. 2, pp. E14-E19. Open access 20 20 3
2017	Wang, H, Sun, Q, Vitry, A & Nguyen, TA 2017, 'Availability, prices and affordability of selected essential medicines for chronic diseases in 11 countries of the Asia Pacific Region: a secondary analysis', Asia-Pacific Journal of Public Health, 29, no. 4, pp. 268–277. 16 16 11
2016	Caughey, G, Vitry, A, Ramsay, E, Gilbert, A, Shakib, S, Ryan, P, Esterman, A, McDermott, R & Roughead, E 2016, 'Effect of a general practitioner management plan on health outcomes and hospitalisations in older patients with diabetes', Internal Medicine Journal, vol. 46, no. 12, pp. 1430-1436. Open access 8 9 29
2016	Hillen, JB, Vitry, A & Caughey, GE 2016, 'Trends in general practitioner services to residents in aged care', Australian Journal of Primary Health, vol. 22, no. 6, pp. 517-522. 6 5 1
2016	Hopkins, AM, Proudman, SM, Vitry, A, Sorich, MJ, Cleland, LG & Wiese, MD 2016, 'Ten years of Publically Funded Biological Disease Modifying Antirheumatic Agents in Australia', Medical Journal of Australia, vol. 204, no. 2, pp. 64-68. Open access 14 3 1
2016	Tan, EC, Visvanathan, R, Hilmer, SN, Vitry, A, Emery, T, Robson, L, Pitkälä, K, Ilomäki, J & Bell, JS 2016, 'Analgesic use and pain in residents with and without dementia in aged care facilities: a cross-sectional study', Australasian Journal on Ageing, vol. 35, no. 3, pp. 180-187. Open access 20 22 4
2016	Thai, L, Moss, J, Godman, B & Vitry, A 2016, 'Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme', Expert Review of Pharmacoeconomics and Outcomes Research: Informing Decision-Making in the Delivery of Cost-Effective Healthcare, vol. 16, no. 3, pp. 419-433. Open access 3 2
2016	Thai, LP, Vitry, A I & Moss, JR 2016, 'Pricing and utilisation of proton pump inhibitors in South Australian public hospitals and the Pharmaceutical Benefits Scheme', Journal of Pharmacy Practice and Research, vol. 46, no. 2, pp. 130-136. 2
2016	Vitry, A, Mintzes, B & Lipworth, W 2016, 'Access to new cancer medicines in Australia: dispelling the myths and informing a public debate', Journal of Pharmaceutical Policy and Practice, vol. 9, no. 13, pp. 1-6. Open access 13 9
2016	Vogler, S, Vitry, A I & Babar, Z-U-D 2016, 'Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study', Lancet Oncology, vol. 17, no. 1, pp. 39-47. 106 96 276
2015	Godman, B, Wilcock, M, Martin, A, Bryson, S, Vitry, AI & Malmström, RE and 33 other authors 2015, 'Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future', GaBI Journal, vol. 4, no. 3, pp. 125-135. Open access 9 10
2015	Hillen, JB, Vitry, A & Caughey, G 2015, 'Evaluating medication-related quality of care in residential aged care: a systematic review', SpringerPlus, vol. 4, no. 220, pp. 1-17. Open access 17 14
2015	Othman, N, Vitry, A I, Roughead, EE, Ismail, SB & Omar, K 2015, 'Doctors' views on the quality of claims provided by pharmaceutical representatives: a comparative study in Malaysia and Australia', Journal of Taibah University Medical Sciences, vol. 10, no. 4, pp. 471-480. Open access 3 2 7
2015	Tan, ECK, Visvanathan, R, Hilmer, SN, Emery, T, Robson, L, Vitry, A, Hughes, JM, Jones, MJ, Moawad, S, Ilomaki, J, Quirke, T & Bell, JS 2015, 'Analgesic use and daytime sleepiness in residents with and without dementia in residential aged care facilities', Drugs and Aging, vol. 32, no. 12, pp. 1045-1053. 5 9
2015	Vitry, A, Nguyen, T, Entwistle, V & Roughead, E 2015, 'Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study', Journal of Pharmaceutical Policy and Practice, vol. 8, no. 25, pp. 1-11. Open access 7 10
2014	Kelly, E, Lu, C, Albertini, S & Vitry, A 2014, 'Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison', Journal of Clinical Pharmacy and Therapeutics, vol. 40, no. 1, pp. 76-82. 16 13 1
2014	Tan, EC, Visvanathan, R, Hilmer, SN, Vitry, A I, Quirke, T, Emery, T, Robson, L, Shortt, T, Sheldrick, S, Lee, SW, Clothier, R, Reeve, E, Gnjidic, D, Ilomaki, J & Bell, JS 2014, 'Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol', BMJ Open, vol. 4, no. 6, article number e005757, pp. 1-6. Open access 30 31 1
2014	Thai, LP, Vitry, A I & Moss, JR 2014, 'Discounting of medicines in Australian community pharmacies', Australian Health Review, vol. 38, no. 5, pp. 517-522. 2 1 5
2014	Vitry, A & Roughead, E 2014, 'Managed entry agreements for pharmaceuticals in Australia', Health Policy, vol. 117, no. 3, pp. 345-352. 21 33 10
2014	Vitry, AI, Nguyen, TA, Ramsay, EN, Caughey, GE, Gilbert, AL, Shakib, S, Ryan, P, Esterman, AJ, McDermott, RA & Roughead, EE 2014, 'General practitioner management plans delaying time to next potentially preventable hospitalization for patients with heart failure', Internal Medicine Journal, vol. 44, no. 11, pp. 1117-1123. Open access 13 11 7
2013	Caughey, GE, Preiss, A, Vitry, AI, Gilbert, AL & Roughead, EE 2013, 'Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications', Diabetes Care, vol. 36, no. 10, pp. 3009-3014. Open access 40 39 17
2013	Caughey, GE, Preiss, AK, Vitry, A I, Gilbert, AL, Ryan, P, Shakib, S, Esterman, A, McDermott, RA & Roughead, EE 2013, 'Does antidepressant medication use affect persistence with diabetes medicines?', Pharmacoepidemiology and Drug Safety, vol. 22, no. 6, pp. 615-622. Open access 15 13 3
2013	Gabb, G, Vitry, A, Limaye, V & Alhami, G 2013, 'Serious statin-associated myotoxicity and rhabdomyolysis in Aboriginal and Torres Strait Islanders: a case series', Internal Medicine Journal, vol. 43, no. 9, pp. 987-992. 15 13 3
2013	Vitry, AI, Ng, HS & Vitre, P 2013, 'Assessment of the therapeutic value of new medicines marketed in Australia', Journal of Pharmaceutical Policy and Practice, vol. 6, article no. 2. Open access 9 18
2012	Baumgärtel, C, Godman, B, Malmstrom, RE, Andersen, M, Vitry, AI & Gustafsson, LL and 22 other authors 2012, 'What lessons can be learned from the launch of generic clopidogrel?', GaBI Journal, vol. 1, no. 2, pp. 58-68. Open access
2012	Godman, B, Abuelkhair, M, Vitry, A, Abdu, S, Bennie, M, Bishop, I, Fahmy, S, Garuoliene, K, Herholz, H, Martin, A, Malmstrom, R, Jan, S, Schwabe, U, Sermet, C, Skiold, P, Voncina, L & Gustaffson, L 2012, 'Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach', GaBI Journal, vol. 1, no. 2, pp. 69-83. Open access
2012	Vitry, A I & Mintzes, B 2012, 'Disease mongering and low testosterone in men: the tale of two regulatory failures', Medical Journal of Australia, vol. 196, no. 10, pp. 619-621. 14 12 4
2012	Vitry, A I, Roughead, EE, Ramsay, EN, Ryan, P, Caughey, GE, Esterman, A, Shakib, S, Gilbert, AL & McDermott, R 2012, 'Chronic disease management: does the disease affect likelihood of care planning?', Australian Health Review, vol. 36, no. 4, pp. 419-423. 8 8 3
2011	Caughey, GE, Roughead, EE, SHAKIB, S, Vitry, AI & Gilbert, AL 2011, 'Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data', Drugs and Aging, vol. 28, no. 7, pp. 575-581. 32 23
2011	Gilbert, AL, Caughey, GE, Vitry, AI, Clark, AB, Ryan, P, McDermott, RA, SHAKIB, S, Luszcz, M, Esterman, AJ & Roughead, EE 2011, 'Ageing well: improving the management of patients with multiple chronic health problems', Australasian Journal on Ageing, vol. 30, no. S2, pp. 32-37. 17 18
2011	Lu, CY, Barratt, J, Vitry, A & Roughead, E 2011, 'Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting', Journal of Clinical Epidemiology, vol. 64, no. 2, pp. 223-228. 59 58
2011	Roughead, EE, Vitry, A I, Caughey, GE & Gilbert, AL 2011, 'Multimorbidity, care complexity and prescribing for the elderly', Aging Health, vol. 7, no. 5, pp. 695-705. 28
2011	Vitry, A I, Roughead, EE, Ramsay, EN, Preiss, AK, Ryan, P, Gilbert, AL, Caughey, GE, Shakib, S, Esterman, A, Zhang, Y & McDermott, RA 2011, 'Major bleeding risk associated with warfarin and co-medications in the elderly population', Pharmacoepidemiology and Drug Safety, vol. 20, no. 10, pp. 1057-1063. 46 39
2011	Vitry, A, Thai, L & Lu, C 2011, 'Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia', Internal Medicine Journal, vol. 41, no. 2, pp. 162-166. 10 9
2011	Zhang, Y, Vitry, A, Caughey, G, Roughead, EE, Ryan, P, Gilbert, A, Shakib, S & McDermott, R 2011, 'The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes', Diabetes Research and Clinical Practice, vol. 91, no. 1, pp. 115-120. 4 3
2010	Caughey, GE, Ramsay, E, Vitry, AI, Gilbert, AL, Luszcz, M, Ryan, P & Roughead, EE 2010, 'Comorbid chronic diseases, discordant impact on mortality in the elderly; a 14 year longitudinal population study', Journal of Epidemiology and Community Health, vol. 64, no. 12, pp. 1036-1042. Open access 51 45
2010	Caughey, GE, Roughead, EE, Pratt, N, Shakib, S, Vitry, A I & Gilbert, AL 2010, 'Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?', Pharmacoepidemiology and Drug Safety, vol. 19, no. 9, pp. 977-982. 43 38
2010	Caughey, GE, Roughead, EE, Shakib, S, McDermott, RA, Vitry, A I & Gilbert, AL 2010, 'Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants', Age and Ageing, vol. 39, no. 4, pp. 488-494. Open access 41 36
2010	Caughey, GE, Roughead, EE, Vitry, AI, McDermott, RA, Shakib, S & Gilbert, AL 2010, 'Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts', Diabetes Research and Clinical Practice, vol. 87, no. 3, pp. 385-393. 124 111
2010	Othman, N, Vitry, A I, Roughead, EE, Ismail, SB & Omar, K 2010, 'Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia', BMC Public Health, vol. 10, article no. 743, pp.1-11. Open access 25 17
2010	Othman, N, Vitry, AI & Roughead, EE 2010, 'Medicines information in medical journal advertising in Australia, Malaysia and the United States: A comparative cross-sectional study', Southern Med Review, vol. 3, no. 1, pp. 11-18. 9
2010	Othman, N, Vitry, AI & Roughead, EE 2010, 'Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States', BMC Public Health, vol. 10, article no. 294. Open access 15 13
2010	Roughead, EE, Vitry, AI, Preiss, A, Barratt, JD, Gilbert, AL & Ryan, P 2010, 'Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease', European Journal of Preventative Cardiology, vol. 17, no. 1, pp. 71-76. 12 12
2010	Sorich, MJ, Vitry, AI, Ward, MB, Horowitz, J & McKinnon, RA 2010, 'Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data ', Journal of Thrombosis and Haemostasis, vol. 8, no. 8, pp. 1678-1684. 80 69
2010	Spurling, GK, Mansfield, P, Montgomery, BD, Lexchin, J, Doust, J, Othman, N & Vitry, AI 2010, 'Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review', PLoS Medicine, vol. 7, no. 10, article no. e1000352. Open access 339 284
2010	Vitry, A I, Hoile, AP, Gilbert, AL, Esterman, A & Luszcz, MA 2010, 'The risk of falls and fractures associated with persistent use of psychotropic medications in elderly people', Archives of Gerontology and Geriatrics, vol. 50, no. 3, pp. e1-4. 18 13
2010	Vitry, A I, Roughead, EE, Preiss, AK, Ryan, P, Ramsay, EN, Gilbert, AL, Caughey, GE, Shakib, S, Esterman, A, Zhang, Y & McDermott, RA 2010, 'Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study', PLoS One, vol. 5, no. 11, article no. e14024. Open access 31 30
2010	Vitry, AI 2010, 'Reporting of Studies on New Medicines in Major Medical Journals: A Case Study in Breast Cancer', Clinical Pharmacology and Therapeutics, vol. 87, no. 4, pp. 398-400. 5 5
2010	Vitry, AI 2010, 'The imperative of happiness for women living with breast cancer', Canadian Woman Studies, vol. 28, no. 2-3, pp. 30-33.
2010	Zhang, Y, Chow, V, Vitry, A I, Ryan, P, Roughead, EE, Caughey, GE, Ramsay, EN, Gilbert, AL, Esterman, A & Luszcz, MA 2010, 'Antidepressant use and depressive symptomatology among older people from the Australian longitudinal study of ageing', International Psychogeriatrics, vol. 22, no. 3, pp. 437-444. Open access 21 20
2010	Zhang, Y, Vitry, AI, Roughead, EE, Ryan, P & Gilbert, AL 2010, 'Co-morbidity and the utilization of health care for Australian veterans with diabetes', Diabetic Medicine, vol. 27, no. 1, pp. 65-71. 13 10
2009	Goh, LY, Vitry, A I, Semple, SJ, Esterman, A & Luszcz, MA 2009, 'Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population', BMC Complementary and Alternative Medicine, vol. 9, article no. 1472. Open access 83 72
2009	Othman, N, Vitry, A & Roughead, EE 2009, 'Quality of pharmaceutical advertisements in medical journals : a systematic review', PLoS One, vol. 4, no. 7, article no. e6350, pp. 1-11. Open access 79 63
2009	Thomas, R & Vitry, A 2009, 'Consumers' perceptions of generic medicines in community pharmacies in Malaysia', Southern Med Review, vol. 2, no. 2, pp. 20-23.
2009	Vitry, A & Lai, Y 2009, 'Advertising of antihypertensive medicines and prescription sales in Australia', Internal Medicine Journal, vol. 39, no. 11, pp. 728-732. 6 6
2009	Vitry, A, Gilbert, A, Mott, K, Rao, D & March, G 2009, 'Provision of medicines information in Australian community pharmacies', International Journal of Clinical Pharmacy, vol. 31, no. 2, pp. 154-157. 5 4
2009	Vitry, A, Wong, SA, Roughead, EE, Ramsay, E & Barratt, J 2009, 'Validity of medication-based co-morbidity indices in the Australian elderly population', Australian and New Zealand Journal of Public Health, vol. 33, no. 2, pp. 126-130. Open access 83 80
2009	Vitry, AI 2009, 'Does Direct-to-Consumer Prescription Drug Advertising Do More Harm Than Good?', Annals of Internal Medicine, vol. 151, no. 11, pp. 823-824. 1 1
2009	Vitry, AI 2009, 'Written medicine information in Australia, answer to the letter to the editor.', International Journal of Clinical Pharmacy, vol. 31, no. 6, pp. 605-606. 1
2009	Vitry, AI, Bertele, V & Garattinii, S 2009, 'Drug regulations and the need for greater transparency', The Regulatory Affairs Journal. Pharma, March, pp. 143-146.
2008	Caughey, GE, Vitry, AI, Gilbert, AL & Roughead, EE 2008, 'Prevalence of comorbidity of chronic diseases in Australia', BMC Public Health, vol. 8, article no. 221. Open access 159 138
2008	Roughead, EE, Gilbert, AL & Vitry, AI 2008, 'The Australian funding debate on quadrivalent HPV vaccine: A case study for the national pharmaceutical policy', Health Policy, vol. 88, no. 2-3, pp. 250-257. 24 21
2008	Vitry, AI & Zhang, Y 2008, 'Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions', Medical Journal of Australia, vol. 189, no. 7, pp. 360-365. Open access 75 29
2008	Vitry, AI 2008, 'Time for Transparency at teh TGA'.
2008	Vitry, AI 2008, 'Time for transparency at the TGA', Australian Prescriber.
2008	Vitry, AI, Lexchin, J, Sasich, L, Dupin-Spriet, T, Reed, T, Bertele, V, Garattinii, S, Toop, L & Hurley, E 2008, 'Provision of information on regulatory authorities' websites', Internal Medicine Journal, vol. 38, no. 7, pp. 559-567. 23 15
2008	Vitry, AI, Phillips, S & Semple, SJ 2008, 'Quality and availability of consumer information on heart failure in Australia', BMC Health Services Research, vol. 8, article no. 255. Open access 7 6

Conferences

Year	Output
2014	Hillen, J, Vitry, A & Caughey, G 2014, 'Epidemiology of disease, medication use and health service utilisation in Australian residential aged care. Implications for evaluating medication-related quality of care', 13th National Conference of Emerging Researchers in Ageing, Flinders University, pp. 76-83. Open access

Reports

Year	Output
2016	Vitry, A, Nguyen, T, Roughead, E, Baer, B, Bhushan, A & Tisocki, K 2016, Older people's access to medicines and assistive in the Western Pacific Region, World Health Organization, Western Pacific Region, Switzerland. Open access

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Alzheimers Australia	AUSTRALIA
Australian Medicines Handbook Pty Ltd	AUSTRALIA
Austrian Health Institute	AUSTRIA
Austrian Medicines and Medical Devices Agency	AUSTRIA
Consumer Dementia Research Network	AUSTRALIA
Deakin University	AUSTRALIA
Dental and Pharmaceuticals Benefits Agency	SWEDEN
Flinders University	AUSTRALIA
Harvard University	UNITED STATES
Health Action International	NETHERLANDS
Health Authority - Abu Dhabi	UNITED ARAB EMIRATES
International Islamic University Malaysia	MALAYSIA
IRDES	FRANCE
Karolinska Institute	SWEDEN
Mario Negri Institute for Pharmacological Research	ITALY
Ministry of Health - Croatia	CROATIA
Ministry of Health, Republic of Indonesia	INDONESIA
Monash University	AUSTRALIA
National Health Insurance Fund	SERBIA
National University of Malaysia	MALAYSIA
New Jersey City University	UNITED STATES
NHS England	UNITED KINGDOM
NHS Greater Glasgow and Clyde Board HQ	UNITED KINGDOM
North West Commissioning Support Unit	UNITED KINGDOM
Princess Alexandra Hospital	AUSTRALIA
Resthaven Incorporated	AUSTRALIA
Resthaven Limited	AUSTRALIA
Royal Adelaide Hospital	AUSTRALIA
Royal Cornwall Hospitals NHS Trust	UNITED KINGDOM
Shandong University	CHINA
South Australian Health and Medical Research Institute (SAHMRI)	AUSTRALIA
Taibah University	SAUDI ARABIA
The University of Notre Dame Australia	AUSTRALIA
Universiti Kabangsaan Malaysia	MALAYSIA
University of Aberdeen	UNITED KINGDOM
University of Adelaide	AUSTRALIA
University of Auckland	NEW ZEALAND
University of British Columbia	CANADA
University of Heidelberg	GERMANY
University of Helsinki	FINLAND
University of Huddersfield	UNITED KINGDOM
University of Lille 2	FRANCE
University of Liverpool	UNITED KINGDOM
University of Otago	NEW ZEALAND
University of Queensland	AUSTRALIA
University of Science, Malaysia	MALAYSIA
University of South Australia	AUSTRALIA
University of Strathclyde	UNITED KINGDOM
University of Sydney	AUSTRALIA
University of Western Australia	AUSTRALIA
University of York	UNITED KINGDOM
World Health Organisation	SWITZERLAND
York University	CANADA

External engagement & recognition

Engagement/recognition	Year
Consultant / advisor, Cancer Australia Consumer Network Cancer Australia, Australian Government	2017
Member International Society for Pharmacoepidemiology (ISPE)	2017
Member Health Technology Assessment International (HTAi)	2017
Consultant / advisor, Cancer Australia Consumer Network Cancer Australia, Australian Government	2016
Consultant / advisor, Cancer Australia Consumer Network Cancer Australia, Australian Government	2015
Consultant / advisor, Cancer Australia Consumer Network Cancer Australia, Australian Government	2014
Best of the Best Poster Presentation Awards Clinical Oncology Society of Australia	2013
Consultant / advisor, Cancer Australia Consumer Network Cancer Australia, Australian Government	2013
Invited presentation Flinders Centre for Innovation in Cancer Survivorship Conference	2013
Consultant / advisor, Cancer Australia Consumer Network Cancer Australia, Australian Government	2012
Consultant / advisor, Cancer Australia Consumer Network Cancer Australia, Australian Government	2011
Consultant / advisor, Cancer Australia Consumer Network Cancer Australia, Australian Government	2010
Member, Program Reference Group (implementation and the evaluation of the $731m Fifth Community Agreement between the Commonwealth government and the Pharmacy Guild of Australia) Australian Government	2010

Teaching & student supervision

Research degree supervision

Supervisions from 2010 shown

Thesis title	Student status
Pharmacogenomics to achieve precision dosing of fluoropyrimidines (FP) in cancer patients	Current
Age and comorbidity: their influence on colorectal cancer stage, treatment and survival in South Australia	Completed
Assessment of the burden, types and development of comorbidities in the Australian population with cancer	Completed
Indicators for evaluating medication-related quality of care in Australian residential aged care	Completed
Quality of information in pharmaceutical promotion	Completed
The impact of pricing policies on Australia's medicines market	Completed

more less

Dr Agnes Vitry

About me

About me

UniSA Clinical & Health Sciences

About me

Professional Associations

Experience

Qualifications

Research

Research focus

Highlights

Projects

Outputs

Chapters

Journal Articles

Conferences

Reports

Current research & highlights

External engagement & recognition

Collaborations

Collaborations

External engagement & recognition

Consultant / advisor, Cancer Australia Consumer Network

Member

Member

Consultant / advisor, Cancer Australia Consumer Network

Consultant / advisor, Cancer Australia Consumer Network

Consultant / advisor, Cancer Australia Consumer Network

Best of the Best Poster Presentation Awards

Consultant / advisor, Cancer Australia Consumer Network

Invited presentation

Consultant / advisor, Cancer Australia Consumer Network

Consultant / advisor, Cancer Australia Consumer Network

Consultant / advisor, Cancer Australia Consumer Network

Member, Program Reference Group (implementation and the evaluation of the $731m Fifth Community Agreement between the Commonwealth government and the Pharmacy Guild of Australia)

Teaching & student supervision

Courses and programs

Research degree supervision

Gallery